White label ELPA - ClinicalTrials.eu

Study on Empagliflozin for Patients with Aortic Stenosis After Aortic Valve Replacement

Not recruiting

3 1 1
Investigated Diseases:
- Aortic stenosis
Investigated Drugs:
- Empagliflozin
Study on the Safety and Effectiveness of Elezanumab for Adults with Acute Traumatic Cervical Spinal Cord Injury

Not recruiting

2 1
Investigated Diseases:
- Spinal cord injury cervical
Investigated Drugs:
- Elezanumab
Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Not recruiting

3 1 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
+5
Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Not recruiting

3 1 1
Investigated Drugs:
+2
Study on the Effectiveness and Safety of Deucravacitinib for Adults with Chronic Hand Eczema

Not recruiting

2 1 1
Investigated Diseases:
- Hand dermatitis
Investigated Drugs:
- Deucravacitinib
Study on the Effectiveness of Dexmedetomidine, Ropivacaine, and Dexamethasone for Pain Relief in Patients Undergoing Shoulder Surgery

Not recruiting

3 1 1
Investigated Drugs:
Study on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression

Not recruiting

3 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
+2
Study of Risdiplam for Infants with Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

Not recruiting

2 1 1 1
Investigated Diseases:
- Spinal muscular atrophy
Investigated Drugs:
- Risdiplam
Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+4
Gene Therapy Study for Patients with Limb-Girdle Muscular Dystrophy Using GNT0006

Not recruiting

2 1 1 1
Investigated Diseases:
- Muscular dystrophy
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies